Light Horse’s CEO said the biotech’s initial focus will be on “high-value and historically challenging” oncology targets.

Our fair value estimate for WuXi is HKD 24.60 per share. WuXi has been growing at a CAGR of 53.3% for the past eight years. Although its USD 20.5 billion total backlog revenue supports our growth ...

With the intensification of global population aging, muscle atrophy, characterized by the loss of muscle mass and function, ...

A new era, where AI is at the centre of the drug discovery process is emerging, says Charlotte Deane, a professor of ...

Research suggests a new drug slowed the growth of prostate cancer cells, including those with a resistance to the hormone ...

Scientists have long considered ketones (a fundamental chemical class) and esters (molecules formed when an acid reacts with ...

By mid-2025, the biotech will split into two entities: a new, as-yet-unnamed innovative medicines specialist and a cell ...

The affidavit states that agents had been tracking the cars using GPS after previously discovering that 36 bricks of cocaine ...

Novo Nordisk on Wednesday announced an expanded deal with healthtech firm Valo Health to use AI to fuel drug discovery.

Absci will use AMD’s $20 million investment to enhance its AI models. In parallel, the companies will collaborate to develop ...

Authorities said they found about 56 grams of Methamphetamine (ICE), about 112 grams of crack and powder Cocaine, about 500 ...

AI drug creation company Absci Corporation (NASDAQ:ABSI) shares are trading higher in premarket on Wednesday after the ...